Abstract
The last major improvement in the outlook for children with acute lymphoblastic leukaemia (ALL) took place around the late 1960s and early 1970s, with the more or less simultaneous introduction of early prophylactic treatment of the central nervous system (CNS) and continuing combination chemotherapy. Since that time, although detailed examination of all aspects of treatment has led to minor advances, there has been no further great stride forward, and treatment remains eventually unsuccessful in about half of all such patients. Meanwhile, however, real advances have been made in the classification of the acute leukaemias, and the prognostic significance of various presenting features has been more closely defined. This new knowledge has influenced the design of therapeutic trials, but it remains to be seen whether prognostic differences can be overcome by the use of more aggressive approaches to the less favourable groups.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Cooperative Group (1981) The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 47: 553–561
Bloomfield CD, Peterson LC, Yunis JJ, Brunning RD (1977) The Philadelphia chromosome (Ph’) in adults presenting with acute leukaemia: a comparison of Ph’ + and Ph’ — patients. Br J Haematol 36: 347–358
Chessells JM (1982) Some aspects of treatment of childhood leukaemia. In: Valman HB (ed) Topics in paediatrics 3. Recent advances in paediatric therapeutics. Pitman, London, pp 129–138
Chessells JM, Breatnach F (1981) Late marrow relapses in childhood acute lymphoblastic leukaemia. Br Med J 283: 649–751
Chessells JM, Hardisty RM, Rapson NT, Greaves MF (1977) Acute lymphoblastic leukaemia in children: classification and prognosis. Lancet 2: 1307–1309
Chessells JM, Janossy G, Lawler SD, Secker-Walker LM (1979) The Ph’ chromosome in childhood leukaemia. Br J Haematol 41: 25–41
Cornbleet MA, Chessells JM (1978) Bone-marrow relapse in acute lymphoblastic leukaemia in childhood. Br Med J 2: 104–106
Eiser C (1978) Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation. Arch Dis Child 53: 391–395
Eiser C (1980) Effects of chronic illness on intellectual development. A comparison of normal children with those treated for childhood leukaemia and solid tumours. Arch Dis Child 55: 766–770
Ekert H, Ellis WM, Waters KD, Matthews RM (1979) Poor outlook for childhood acute lymphoblastic leukaemia with relapse. Med J Aust 2: 224–226
Freeman AI, Wang JJ, Sinks LF (1977) High dose methotrexate in acute lymphocytic leukemia. Cancer Treat Rep 61: 727–731
George SL, Aur RJA, Mauer AM, Simone JV (1979) A reappraisal of the results of stopping therapy in childhood leukemia. New Engl J Med 300: 269–273
Greaves MF (1981) Biology of acute lymphoblastic leukaemia. Leukaemia Research Fund. 16th Annual Guest Lecture
Greaves MF, Brown G, Rapson NT, Lister TA (1975) Antisera to acute lymphoblastic leukaemia cells. Clin Immunol Immunopathol 4: 67–84
Greaves MF, Verbi W, Vogler L, Cooper M, Ellis R, Ganeshaguru K, Hoffbrand V, Janossy G, Bollum FJ (1979) Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leukaemia Res 3: 353–362
Greaves MF, Delia D, Janossy G, Rapson N, Chessells J, Woods M, Prentice G (1980) Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic `lymphoid’ cells. Leuk Res 4: 15–32
Greaves MF, Janossy G, Peto J, Kay HEM (1981) Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Br J Haematol 48: 179–197
Gribbin MA, Hardisty RM, Chessells JM (1977) Long-term control of central nervous system leukaemia. Arch Dis Child 52: 673–678
Ha K, Baba K, Ikeda T, Nishida M, Yabuuchi H, Takahashi M (1980) Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics 65: 346–350
Haghbin M (1976) Chemotherapy of acute lymphoblastic leukemia in children. Am J Hematol 1: 201–209
Hardisty RM (1982) Prophylaxis of central-nervous-system leukaemia: British experience, 1970–80. Proceedings of the International Pediatric Oncology Conference, Rome, October 1981, pp 140–143
Hardisty RM, Till MM (1968) Acute leukaemia 1959–1964: factors affecting prognosis. Arch Dis Child 43: 107–115
Hardisty RM, McElwain TJ, Darby CW (1969) Vincristine and prednisolone for the induction of remission in acute childhood leukaemia. Br Med J 2: 662–665
Hardisty RM, Till MM, Peto J (1981) Acute lymphoblastic leukaemia: four-year survivals old and new. J Clin Pathol 34: 249–253
Henze G, Langermann H-J, Ritter J, Schellong G, Riehm H-J (1981) Treatment strategy for different risk groups in childhood acute lymphoblastic leukaemia. A report from the BFM Study Group. In: Neth R, Gollo RC, Hofschneider PH, Monnweiler K (eds) Modern trends in human leukaemia IV. Springer-Verlag, Heidelberg, pp 87–93
Hughes WT, Feldman S, Aur RJA, Verzosa MS, Hustu HO, Simone JV (1975) Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36: 2004–2009
Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemo-prophylaxis for Pneumocystis carinii pneumonitis. New Engl J Med 297: 1419–1426
Hustu HO, Aur RJA (1978) Extramedullary leukaemia. Clin Haematol 7: 313–337
Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R (1981) A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukaemia in second or subsequent remission. N Engl J Med 305: 846–851
Kay HEM, Knapton PJ, O’Sullivan JP, Wells DG, Harris DG, Harris RF, Innes EM, Stuart J, Schwartz FCM, Thompson EN (1972) Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child 47: 344–354
Mandelli F, Amadori S, Rajnoldi AC, di Montezemolo LC, Madon E, Masera G, Meloni G, Pacilli L, Paolucci G, Pastore G, Rosito P, Uderzo C, Vecchi V (1980) Discontinuing therapy in childhood acute lymphocytic leukaemia. Cancer 46: 1319–1323
Medical Research Council (1971) Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G), intermittent methotrexate, and no therapy after a two-month intensive cytotoxic regimen. Br Med J 4: 189–194
Medical Research Council (1978) Testicular disease in acute lymphoblastic leukaemia in childhood. Br Med J 1: 334–338
Medical Research Council (1982) Duration of chemotherapy in childhood acute lymphoblastic leukemia (ALL). Med Pediatr Oncol (in press)
Miller DR (1975) Prognostic factors in childhood leukemia. J Pediatr 87: 672–676
Miller DR, Leikin S, Albo V, Vitale L, Sather H, Coccia P, Nesbit M, Karon M, Hammond D (1980) Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children’s Cancer Study Group report. Cancer treat Rep 64: 381–392
Miller DR, Leikin S, Albo V, Sather H, Hammond D (1981) Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia ( ALL ). Br J Haematol 48: 199–206
Nesbit ME, Robison LL, Ortega JA, Sather HN, Donaldson M, Hammond D (1980) Testicular relapse in childhood acute lymphoblastic leukemia: association with pretreatment, patient characteristics and treatment. Cancer 45: 2009–2016
Nesbit ME, D’Angio GJ, Sather HN, Robison LL, Ortega J, Donaldson M, Hammond GD (1981a) Effect of isolated central nervous system leukaemia on bone marrow remission and survival in childhood acute lymphoblastic leukaemia: association with pretreatment, patient characteristics and treatment. Lancet 1: 1386–1389
Nesbit ME, Sather HN, Robison LL, Ortega J, Littman PS, D’Angio GJ, Hammond GD (1981b) Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1,800 rad and 2,400 rad. Lancet 1: 461–466
Netzel B, Haas RJ, Rodt H, Kolb HJ, Thierfelder S (1980) Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia. Lancet 1: 1330–1332
Ninane J, Chessells JM (1981) Serious infections during continuing treatment of acute lymphoblastic leukaemia. Arch Dis Child 56: 841–844
Ortega JA, Nesbit ME, Donaldson MII, Hittle RE, Weiner J, Karon M, Hammond D (1977) L-asparaginase, vincristine and prednisone for induction of first remission in acute lymphocytic leukaemia. Cancer Res 37: 535–540
Palmer MK, Hann I, Jones PM, Evans DIK (1980) A score at diagnosis for predicting length of remission in childhood lymphoblastic leukaemia. Br J Cancer 42: 841–849
Prentice HG, Smyth JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy G, Goldstone AH, Hoffbrand AV (1980) Remission induction with adenosine-deaminase inhibitor 2’-deoxycoformycin in thylymphoblastic leukaemia. Lancet 2: 170–172
Prentice HG, Russell NH, Lee N, Ganeshaguru K, Blacklock H, Piga A, Smyth JF, Hoffbrand AV (1981) Therapeutic selectivity of and prediction of response to 2’-deoxycoformycin in acute leukaemia. Lancet 2: 1250–1253
Rapson NT, Cornbleet MA, Chessells JM, Bennett T, Hardisty RM (1980) Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. Br J Haematol 45: 41–52
Ritz J, Schlossman SF (1982) Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59: 1–11
Rivera G, Evans WE, Dahl GV, Yee GC, Pratt CB (1980) Phase 1 clinical and pharmacokinetic study of 4’(9-acridimylamino-methanesulfon-m-aniside) in children with cancer. Cancer Res 40: 4250–4253
Rubinstein LJ, Herman MM, Long TF, Wilbur JR (1975) Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35: 291–305
Sather H, Coccia P, Nesbit M, Level C, Hammond D (1981) Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia. Cancer 48: 370–376
Secker-Walker LM, Lawler SD, Hardisty RM (1978) Prognostic implications of chromosome findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 2: 1529–1530
Seeker-Walker LM, Swansbury GJ, Hardisty R, Sallan SE, Garson OM, Sakurai M, Lawler SD (1982) Cytogenetics of acute lympoblastic leukaemia in children as a factor in the prediction of long term survival. Br J Haematol (in press)
Selby PJ, Powles RL, Jameson BJ, Kay HEM, Watson JG, Thornton R, Morgenstern G, Clink HM, McElwain TJ, Prentice HG, Corringham R, Ross MG, Hoffbrand AV, Brigden D (1979) Parenteral acyclovir therapy for herpes virus infections in man. Lancet 2: 1267–1270
Simone JV (1976) Factors that influence remission duration in acute lymphocytic leukaemia. Br J Haematol 32: 465–472
Sullivan MP, Perez CA, Herson J, Silva-Sousa M, Land V, Dyment PG, Cahn R, Ayala AG (1980) Radiotherapy (2,500 rad) for testicular leukemia. Local control and subsequent clinical events: A South-West Oncology Group study. Cancer 46: 508–515
Thiel E, Rodt H, Huhn D, Netzel B, Grosse-Wilde H, Ganeshaguru K, Thierfelder S (1980) Multimarker classification of acute lymphoblastic leukemia: evidence for further T sub-groups and evaluation of their clinical significance. Blood 56: 759–772
Vogler LB, Crist WM, Bockman DE, Pearl ER, Lawton AR, Cooper MD (1978) Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. New Engl J Med 298: 872–878
Wells RJ, Weetman RM, Baehner RL (1980) The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemia. J Pediatr 97: 429–432
Willoughby MLN (1976) Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial. Br Med J 1: 864–867
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hardisty, R.M. (1983). Acute Lymphoblastic Leukaemia: Achievements and Prospects. In: Duncan, W. (eds) Paediatric Oncology. Recent Results in Cancer Research, vol 88. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82034-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-82034-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82036-6
Online ISBN: 978-3-642-82034-2
eBook Packages: Springer Book Archive